Latest Articles

Structural biology uses a variety of techniques to determine the 3D structures of biomolecules such as proteins, nucleic acids and their complexes. In this article, we consider the key techniques, their role in structural biology, strengths and limitations.

This article will review advances in multimodal imaging mass spectrometry applications and a computational method to achieve higher resolution from spatial transcriptomics datasets.

In the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis, we highlight some of the most significant psychedelic industry news from the past month. This includes important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.

A new project to map the billions of cells in the human brain is underway. The project, dubbed BICAN (BRAIN Initiative Cell Atlas Network) will exploit rapid advances in genomic and cellular technology to build an atlas of the brain. Technology Networks spoke to project lead Ed Lein to find out more.

Alcohol has complex, unseen and far-reaching effects at the molecular and cellular level, including altering our gut microbiome, accelerating the aging process and even changing the synapses in the brain.

With the world of science rapidly evolving, and a new year beginning, we look at the trends breaking through right now, asking experts: where is the world of science headed?

Organoids have revolutionized biological and medical research and proven to be excellent substitutes for animal models in preclinical studies. Here, we discuss what organoids are and how they have been developed over the years to become popular research tools.

A new study suggests that aspartame, the common sweetener, produces anxiety-like behavior in mice, an effect that was passed on to multiple subsequent generations.

Technology Networks interviews renowned structural biologist-turned molecular artist, Professor David Goodsell.

Michael Kinch confronts a recent controversy in the field of immunology, where researchers failed to seek permission or guidance from the NIAID before engineering mutant forms of SARS-CoV-2.